NEW HAVEN, Conn.--CuraGen said it signed a target discovery and pharmacogenomics collaboration with the Swiss life-sciences company Hoffmann-La Roche last week. Roche said it will apply CuraGen's bioinformatics and genomics expertise to the discovery of animal nutrition and human health products. The deal is designed to evaluate existing product candidates, discover new targets, and facilitate the development of drugs and diagnostic tests.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.